Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1200/JCO.2018.36.15\_suppl.e24306
dc.identifier.other
WOS:000442916007486
dc.description.volume
dc.description.issue
Publisher
AMER SOC CLINICAL ONCOLOGY
DOI
10.1200/JCO.2018.36.15\_suppl.e24306